Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maddali, M. M
Right arrow Articles by Rajakumar, M. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maddali, M. M
Right arrow Articles by Rajakumar, M. C
Related Collections
Right arrow Coronary disease
Asian Cardiovasc Thorac Ann 2007;15:313-319
© 2007 Asia Publishing EXchange Ltd


ORIGINAL CONTRIBUTIONS

Tranexamic Acid and Primary Coronary Artery Bypass Surgery: a Prospective Study

Madan M Maddali, MD, Muthukkumar C Rajakumar, MCh

Departments of Anesthesia and Cardiothoracic Surgery, Royal Hospital, Muscat, Oman

For reprint information contact:Madan M Maddali, MD Tel/Fax: 968 2459 0192 Email: madan{at}omantel.net.om, Royal Hospital, PB No. 1331, PC: 111, Seeb, Muscat, Sultanate of Oman.

Tranexamic acid was used to reduce postoperative drainage and allogenic blood transfusion requirements in patients undergoing on-pump primary coronary bypass surgery. Over 12 months, 222 patients participated in this prospective, randomized, placebo-controlled, double-blind study conducted at a tertiary center. Half of the patients were randomly allocated to receive tranexamic acid as a bolus (10 mg·kg–1) prior to sternotomy, followed by an infusion (1 mg·kg–1·hr–1) up to the time of starting of protamine. The other 111 patients received a saline bolus and infusion. Postoperative drainage and transfusion requirements were measured in all patients. Markers of graft patency, hemostasis, hemodynamic stability, and fibrinolysis were evaluated. Chest closure time, renal function parameters, allergic reactions, incidence of stroke, re-exploration, and hospital mortality were also noted. Postoperative drainage was significantly less and blood conservation considerably better when tranexamic acid was used. Post-bypass hemostasis was achieved faster, fibrinolysis was less, and there was no evidence of increased incidence of graft occlusion in the group given tranexamic acid.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by the Asia Publishing EXchange Ltd.